In an effort to support global initiatives to contain the spread of the new coronavirus (COVID-19), the Academy is presenting Spring 2020 events through online platforms and some of our previously scheduled events are being postponed to a later date. Please check our events listing for the latest information and contact our Customer Service team with any additional questions. For Academy programs and resources about COVID-19, click here.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.


Special Issue: Annals Reports

Edited by

Annals of the New York Academy of Sciences editorial staff.

Special Issue: Annals Reports

Published: December 2016

Volume 1386

Published since 1824, Annals of the New York Academy of Sciences is the Academy’s premier scientific publication.

Learn More

A special issue presenting four papers in different areas of both basic and medical research: (1) a study on potential therapeutic proapoptotic and antiangiogenic applications of low-dose resveratrol treatment in the prevention and treatment of different diseases; (2) an investigation of neural correlates of cognitive function in adults with β-thalassemia using scalp-recorded event-related potentials; and (3) two related papers focused on the molecular and cellular relationships between exposure to specific diseases, and/or their treatments, and recently defined molecular and cellular pillars of aging.